Amanta Healthcare (NSE:AMANTA) Short-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AMANTA Amanta Healthcare Ltd NSE:AMANTA
17 GF Score
Price ₹201.78
! 7 Warning Signs
View Full Analysis

What is Amanta Healthcare Short-Term Debt?

Amanta Healthcare NSE:AMANTA -2.00% 17 Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:AMANTA with a GF Score™ of 17/100. The stock has 7 warning signs investors should review.

Amanta Healthcare's Short-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Amanta Healthcare's quarterly Short-Term Debt increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹724 Mil) but then declined from Mar. 2026 (₹724 Mil) to Jun. 2026 (₹0 Mil).

Amanta Healthcare's annual Short-Term Debt increased from Mar. 2024 (₹562 Mil) to Mar. 2025 (₹626 Mil) and increased from Mar. 2025 (₹626 Mil) to Mar. 2026 (₹724 Mil).

Amanta Healthcare Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Amanta Healthcare Short-Term Debt Related Terms

Amanta Healthcare Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Amanta Healthcare's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amanta Healthcare Short-Term Debt Chart

Amanta Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
457.97 401.08 562.02 626.39 724.48

Amanta Healthcare Quarterly Data
Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 543.81 0.00 724.48 0.00
NSE:AMANTA
17GF Score
Amanta Healthcare Ltd NSE:AMANTA
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹0 Mil mean?
Amanta Healthcare (NSE:AMANTA) has a Short-Term Debt of ₹0 Mil as of Jun. 2026.
Is Amanta Healthcare's Short-Term Debt too high?
Amanta Healthcare's current Short-Term Debt is ₹0 Mil. Overall, Amanta Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Amanta Healthcare's Short-Term Debt compare to ZTS?
Amanta Healthcare's Short-Term Debt of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Amanta Healthcare's current Short-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amanta Healthcare stock overvalued right now?
Amanta Healthcare (NSE:AMANTA) has a current Short-Term Debt of ₹0 Mil. The current Short-Term Debt is ₹0 Mil. Amanta Healthcare's overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Amanta Healthcare (NSE:AMANTA), the current Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amanta Healthcare Business Description

Other Exchanges 544502:India
Address C.J. Marg, 8th Floor, Shaligram Corporates, Ambli, Ahmedabad, GJ, IND, 380058
Amanta Healthcare Ltd is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal and Injection Strech Blow Moulding technology. It manufactures large volume parenterals and small volume parenterals in six therapeutic segments. It also manufactures medical devices. The company manufactures fluid therapy, formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. It offers wide range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume till 1000 ml.
17GF Score

Get the complete analysis for NSE:AMANTA

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹201.78
Price